Salutary potential of ethanolic extract of avocado fruit on anomalous carbohydrate metabolic key enzymes in hepatic and renal tissues of hyperglycaemic albino rats

  • U. S. Mahadeva RaoEmail author
Original Article



To assess the beneficial potential of ethanolic extract of avocado fruit on abnormal carbohydrate metabolic key enzymes in hepatic and renal tissues in streptozotocin (STZ) induced hyperglycemic albino rats.


Twenty-four male albino rats were randomly divided into four groups with six in each group by simple random sampling method. Group 1 as control rats; Group 2 as STZ induced diabetic rats; Group 3 as diabetic rats treated with avocado fruit extract (AFE), 300 mg/kg as aqueous suspension orally for 30 days; Group 4 as diabetic rats treated with gliclazide (5 mg/kg) in aqueous solution orally for 30 days. The rats were fasted overnight and sacrificed by cervical dislocation and the blood was collected for various biochemical analysis and excision of hepatic and kidney were done for histological analysis. Levels of fasting blood glucose, plasma insulin and glycosylated hemoglobin were estimated. The activities of key enzymes in carbohydrate metabolism such as hexokinase, pyruvate kinase, glucose-6- phosphatase, fructose-1, 6-bisphosphatase, glucose-6-phosphate dehydrogenase, glycogen synthase and glycogen phosphorylase were assayed by standard methods described in the methodology.


Oral administration of AFE significantly improved the altered levels of blood glucose, plasma insulin, glycosylated hemoglobin, and modulated the activities of carbohydrate metabolizing enzymes (P<0.05, respectively). The glycogen content in hepatic tissues was significantly increased in diabetic rats treated with AFE (P<0.05, respectively).


AFE plays a pivotal role to maintain normoglycemia in diabetes by modulating the activities of carbohydrate metabolic enzymes.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Scheen AJ. Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments. Drugs 1997;54:355–368.CrossRefPubMedGoogle Scholar
  2. 2.
    Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–1053.CrossRefPubMedGoogle Scholar
  3. 3.
    Villanueva M, Verti S, “Avocado: Green gold mexico, michoacan pride”. Government of the State of Michoacan. Mexico;2007.Google Scholar
  4. 4.
    Barry PC. Avocado: the Early Roots of Avocado History. Canku Ota 2001;33:12–29.Google Scholar
  5. 5.
    SK Lee, RE Young, PM Schiffman, and CW Coggins. Jr. Maturity Studies of Avocado Fruit Based on Picking Dates and Dry Weight. J Amer Soc Hort Sci 1983;108:390–394.Google Scholar
  6. 6.
    Stradley L. “All about avocados: history of the hass Avocado”. What’s Cooking Newberg, Yamhill County, Oregon: United States; 2004Google Scholar
  7. 7.
    Kadam SS, Salunkhe, DK. Avocado. In: Handbook of Fruit Science and Technology, Production, Composition, Storage and Processing. New York: Marcel Dekker Inc.;1995:363.Google Scholar
  8. 8.
    Rakieten N, Rakieten ML, Nadkarni MR. Studies on the diabetogenic action of streptozotocin. Cancer Chemother Reports 29;1963:91–98.Google Scholar
  9. 9.
    Fischer LJ, Rickert DE. Pancreatic islet-cell toxicity. Crit Rev in Toxicol 1975;3:231–263.CrossRefGoogle Scholar
  10. 10.
    Trinder P. Determination of blood glucose using an oxidaseperoxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969;22:158–161.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Nayak SS, Pattabiraman TN. A new colorimetric method for the estimation of glycosylated hemoglobin. Clin Chim Acta 1981;109:267–274.CrossRefPubMedGoogle Scholar
  12. 12.
    Brandstrup N, Kirk JE, Bruni C. The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J Gerontol 1957;12:166–171.CrossRefPubMedGoogle Scholar
  13. 13.
    Pogson CI, Denton RM. Effect of alloxan diabetes, starvation and refeeding on glycolytic kinase activities in rat epididymal adipose tissue. Nature 1967;216:156–157.CrossRefPubMedGoogle Scholar
  14. 14.
    Koide H, Oda T. Pathological occurrence of glucose-6- phosphatase in serum in liver diseases. Clin Chim Acta 1959;4:554–561.CrossRefPubMedGoogle Scholar
  15. 15.
    Gancedo JM, Gancedo C. Fructose-1, 6 diphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting and non-fermenting yeasts. Arch Mikrobiol 1971;76:132–138.CrossRefPubMedGoogle Scholar
  16. 16.
    Ells HA, Kirkman HN. A colorimetric method for assay of erythrocytic glucose-6-phosphate dehydrogenase. Proc Soci Exp Biol Med 1961;106:607–609.CrossRefGoogle Scholar
  17. 17.
    Leloir LF, Goldemberg SH. Glycogen synthetase from rat liver: (Glucose) n+(UDPG) ? (Glucose) n+1+UDP. In: Colowick SP, Kalpan NO (Eds.). Methods in Enzymology. New York: Academic Press;1962:145–147.Google Scholar
  18. 18.
    Cornblath M, Randle PJ, Parmeggiani A, Morgan HE. Regulation of glycogenolysis in muscle. Effects of glucagon and anoxia on lactate production, glycogen content, and phosphorylase activity in the perfused isolated rat heart. J Biolo Chem 1963;238:1592–1597.Google Scholar
  19. 19.
    Morales MA, Jabbagy AJ, Terenizi HR. Mutations affecting accumulation of glycogen. Neurospora News 1973;20:24–25.Google Scholar
  20. 20.
    Soling HD, Kleineke J. Species dependent regulation of hepatic gluconeogenesis in higher animals. In: Hanson RW, Mehlman MA eds. Gluconeogenesis: its regulation in mammalian species. New York: Wiley Interscience: 369-462.Google Scholar
  21. 21.
    Grover JK, Vats V. Shifting paradigm from conventional to alternative medicine. An introduction on traditional Indian medicine. Asia Pac Biotechnol News 2001;5:28–32.CrossRefGoogle Scholar
  22. 22.
    Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman, M, et al. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 1976;295:417–420.CrossRefPubMedGoogle Scholar
  23. 23.
    Asgary S, Naderi G, Sarrafzadegan N, Ghassemi N, Boshtam M, Rafie M, et al. Anti-oxidant effect of flavonoids on hemoglobin glycosylation. Pharm Acta Helv 1999;73:223–226.CrossRefPubMedGoogle Scholar
  24. 24.
    Al-yassin D, Ibrahim K. A minor haemoglobin fraction and the level of fasting blood glucose. J Faculty Med 1981;23:373–380.Google Scholar
  25. 25.
    Nordlie RC, Foster JD, Lange AJ. Regulation of glucose production by the liver. Annu Rev Nutr 1999;19:379–406.CrossRefPubMedGoogle Scholar
  26. 26.
    Shirwaikar A, Rajendran K, Barik R. Effect of aqueous bark extract of Garuga pinnata Roxb. In streptozotocin–nicotinamide induced type-? diabetes mellitus. J Ethnopharmacol 2006;107:285–290.CrossRefPubMedGoogle Scholar
  27. 27.
    Gupta D, Raju J, Prakash J, Baquer NZ. Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats: effect of insulin and vanadate. Diabetes Rese Clin Pract 1999;46:1–7.CrossRefGoogle Scholar
  28. 28.
    Postic C, Shiota M, Magnuson MA. Cell-specific roles of glucokinase in glucose homeostasis. Recent Prog Horm Res 2001;56:195–217.CrossRefPubMedGoogle Scholar
  29. 29.
    Taylor R, Agius L. The biochemistry of diabetes. Biochem J 1988;250:625–640.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Roden M, Bernroider E. Hepatic glucose metabolism in humans-its role in health and disease. Best Prac Res: Clin Endocrinol Metab 2003;17:365–383.CrossRefGoogle Scholar
  31. 31.
    Pilkis SJ, Claus TH. Hepatic gluconeogenesis/glycolysis: regulation and structure/function relationships of substrate cycle enzymes. Annu Rev Nutri 1991;11;465–515.CrossRefGoogle Scholar
  32. 32.
    Xu Y, Osborne BW, Stanton RC. Diabetes causes inhibition of glucose- 6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am J Physiol Ren Physiol 2005;289:F1040–1047.CrossRefGoogle Scholar
  33. 33.
    West IC. Glucose-6-phosphate dehydrogenase: a candidate gene for diabetes. Diabet Med 2002;19:172–174.CrossRefPubMedGoogle Scholar
  34. 34.
    Pederson BA, Schroeder JM, Parker GE, Smith MW, DePaoli-Roach AA, Roach PJ. Glucose metabolism in mice lacking muscle glycogen synthase. Diabet 2005;54:3466–3473.CrossRefGoogle Scholar
  35. 35.
    Roesler WJ, Khandelwal RL. Quantification of glycogen synthase and phosphorylase protein in mouse liver: correlation between enzymatic protein and enzyme activity. Archives Biochem Biophys 1986;244:397–407.CrossRefGoogle Scholar
  36. 36.
    Parker G, Taylor R, Jones D, McClain D. Hyperglycemia and inhibition of glycogen synthase in streptozotocintreated mice: role of O-linked N acetylglucosamine. J Biol Chem 2004;279:20636–20642.CrossRefPubMedGoogle Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  1. 1.Universiti Sultan Zainal Abidin, Kuala TerengganuTerengganuMalaysia

Personalised recommendations